FDA-approved epilepsy drug may help reverse osteoarthritis damage

Summary

Yale researchers identified that FDA-approved epilepsy drug lacosamide may reverse osteoarthritis damage by blocking proteins involved in pain signaling and cartilage destruction in preclinical studies.